Oxana Beskrovnaya

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

DYN

Current role

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Dyne Therapeutics, Inc. (DYN)	Chief Innovation Officer; Former Chief Scientific Officer	$531,500	—	—	$252,153	$201,970	$7,005	$992,628
2024	Dyne Therapeutics, Inc. (DYN)	Chief Scientific Officer	$506,000	—	$1,957,760	$1,158,369	$212,520	$1,001	$3,835,650
2023	Dyne Therapeutics, Inc. (DYN)	Chief Scientific Officer	$477,061	—	$1,019,652	$252,064	$248,072	$996	$1,997,845
2022	Dyne Therapeutics, Inc. (DYN)	Chief Scientific Officer	$450,057	—	$428,800	$426,497	$180,023	$996	$1,486,373
2021	Dyne Therapeutics, Inc. (DYN)	Chief Scientific Officer	$406,875	—	$1,820,317	$479,195	$201,527	$1,038	$2,908,952

No earnings-call appearances or filed executive changes recorded yet.